Literature DB >> 28122885

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Emelia J Benjamin, Michael J Blaha, Stephanie E Chiuve, Mary Cushman, Sandeep R Das, Rajat Deo, Sarah D de Ferranti, James Floyd, Myriam Fornage, Cathleen Gillespie, Carmen R Isasi, Monik C Jiménez, Lori Chaffin Jordan, Suzanne E Judd, Daniel Lackland, Judith H Lichtman, Lynda Lisabeth, Simin Liu, Chris T Longenecker, Rachel H Mackey, Kunihiro Matsushita, Dariush Mozaffarian, Michael E Mussolino, Khurram Nasir, Robert W Neumar, Latha Palaniappan, Dilip K Pandey, Ravi R Thiagarajan, Mathew J Reeves, Matthew Ritchey, Carlos J Rodriguez, Gregory A Roth, Wayne D Rosamond, Comilla Sasson, Amytis Towfighi, Connie W Tsao, Melanie B Turner, Salim S Virani, Jenifer H Voeks, Joshua Z Willey, John T Wilkins, Jason Hy Wu, Heather M Alger, Sally S Wong, Paul Muntner.   

Abstract

Entities:  

Keywords:  AHA Scientific Statements; cardiovascular diseases; epidemiology; risk factors; statistics; stroke

Year:  2017        PMID: 28122885      PMCID: PMC5408160          DOI: 10.1161/CIR.0000000000000485

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  1973 in total

1.  AHA Conference Proceedings. Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: executive summary. American Heart Association.

Authors:  S C Smith; P Greenland; S M Grundy
Journal:  Circulation       Date:  2000 Jan 4-11       Impact factor: 29.690

2.  Prevalence and natural course of ectopic atrial tachycardia.

Authors:  A M Poutiainen; M J Koistinen; K E Airaksinen; E K Hartikainen; R V Kettunen; J E Karjalainen; H V Huikuri
Journal:  Eur Heart J       Date:  1999-05       Impact factor: 29.983

3.  Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators.

Authors:  R G Hart; L A Pearce; R M Rothbart; J H McAnulty; R W Asinger; J L Halperin
Journal:  J Am Coll Cardiol       Date:  2000-01       Impact factor: 24.094

4.  Ventricular pre-excitation in the general population: a study on the mode of presentation and clinical course.

Authors:  J A Goudevenos; C S Katsouras; G Graekas; O Argiri; V Giogiakas; D A Sideris
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

5.  Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls.

Authors:  M Man-Son-Hing; G Nichol; A Lau; A Laupacis
Journal:  Arch Intern Med       Date:  1999-04-12

6.  Prevalence, therapeutic response, and outcome of ventricular tachycardia in the out-of-hospital setting: a comparison of monomorphic ventricular tachycardia, polymorphic ventricular tachycardia, and torsades de pointes.

Authors:  W J Brady; D J DeBehnke; D Laundrie
Journal:  Acad Emerg Med       Date:  1999-06       Impact factor: 3.451

7.  The prevalence and prognosis of third-degree atrioventricular conduction block: the Reykjavik study.

Authors:  E M Kojic; T Hardarson; N Sigfusson; H Sigvaldason
Journal:  J Intern Med       Date:  1999-07       Impact factor: 8.989

8.  Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study.

Authors:  J A Heit; M D Silverstein; D N Mohr; T M Petterson; W M O'Fallon; L J Melton
Journal:  Arch Intern Med       Date:  1999-03-08

9.  Incidence and risk factors for ventricular septal defect in "low risk" neonates.

Authors:  A J Sands; F A Casey; B G Craig; J C Dornan; J Rogers; H C Mulholland
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-07       Impact factor: 5.747

10.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

Authors: 
Journal:  Lancet       Date:  1999-08-07       Impact factor: 79.321

View more
  2000 in total

Review 1.  A systematic comparison of exercise training protocols on animal models of cardiovascular capacity.

Authors:  Rui Feng; Liyang Wang; Zhonguang Li; Rong Yang; Yu Liang; Yuting Sun; Qiuxia Yu; George Ghartey-Kwansah; Yanping Sun; Yajun Wu; Wei Zhang; Xin Zhou; Mengmeng Xu; Joseph Bryant; Guifang Yan; William Isaacs; Jianjie Ma; Xuehong Xu
Journal:  Life Sci       Date:  2018-12-03       Impact factor: 5.037

2.  Palmitic acid methyl ester is a novel neuroprotective agent against cardiac arrest.

Authors:  Reggie Hui-Chao Lee; Alexandre Couto E Silva; HarLee E Possoit; Francesca M Lerner; Po-Yi Chen; Rinata Azizbayeva; Cristiane T Citadin; Celeste Yin-Chieh Wu; Jake T Neumann; Hung Wen Lin
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2018-11-23       Impact factor: 4.006

3.  Geographical variation in the prevalence of obesity and metabolic syndrome among US adolescents.

Authors:  M D DeBoer; S L Filipp; M J Gurka
Journal:  Pediatr Obes       Date:  2018-12-04       Impact factor: 4.000

4.  What Should We Learn From the Recent Decline of Basic Cardiovascular Science in Japan?

Authors:  Junichi Sadoshima; Hitonobu Tomoike
Journal:  Circ Res       Date:  2017-08-04       Impact factor: 17.367

5.  Non-invasive measures of coronary microcirculation: Taking the long road to the clinic.

Authors:  Kieran S Chung; Patricia K Nguyen
Journal:  J Nucl Cardiol       Date:  2017-07-18       Impact factor: 5.952

Review 6.  Sex and gender differences in hypertensive kidney injury.

Authors:  Jennifer C Sullivan; Ellen E Gillis
Journal:  Am J Physiol Renal Physiol       Date:  2017-07-19

7.  Regulation of gene expression in ischemic preconditioning in the brain.

Authors:  Tuo Yang; Qianqian Li; Feng Zhang
Journal:  Cond Med       Date:  2017-12-15

8.  Methylsulfonylmethane decreases inflammatory response to tumor necrosis factor-α in cardiac cells.

Authors:  Lindsey E Miller
Journal:  Am J Cardiovasc Dis       Date:  2018-06-15

9.  Normobaric intermittent hypoxic training regulates microglia phenotype and enhances phagocytic activity.

Authors:  Genell Tantingco; Myoung-Gwi Ryou
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-16

10.  Prevalence of Chronic Kidney Disease, Thrombotic Cardiovascular Events, and Use of Oral P2Y12 Inhibitors among Veterans.

Authors:  Manisha Singh; Deepa Raghavan; James S Williams; Bradley C Martin; Teresa J Hudson; Richard R Owen; Nishank Jain
Journal:  Am J Nephrol       Date:  2018-02-01       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.